From the Department of Plastic and Reconstructive Surgery, Radboud University Medical Center, Radboud Institute for Health Sciences.
Research Center, Velthuis Kliniek.
Plast Reconstr Surg. 2024 Aug 1;154(2):299-309. doi: 10.1097/PRS.0000000000011029. Epub 2023 Aug 29.
To evaluate the success of a breast augmentation, it is essential to measure outcomes from the patient perspective, because a successful aesthetic result is, in particular, determined by the patient. This study aimed to evaluate patient-reported satisfaction with their breasts, and psychosocial, physical, and sexual well-being in patients undergoing breast augmentation using validated questionnaires.
This is a multicenter cohort study based on ongoing routinely collected data. Patient-reported satisfaction and health-related quality of life were assessed with the BREAST-Q augmentation module at intake and 6 months postoperatively.
A total of 1405 patients were included. Large changes in BREAST-Q scores (range, 0 to 100) between intake and 6 months postoperatively were seen in satisfaction with breasts (mean, effect size: +57, 3.8), psychosocial well-being (mean, effect size: +38, 2.1), physical well-being (mean, effect size: -14, -1.2), and sexual well-being (mean, effect size: +44, 2.4). Moreover, improvements in all four scales were not dependent on their intake scores, and all postoperative scores reached similar levels. A decreased physical well-being of the chest was measured after surgery. The satisfaction with breasts scale correlated moderately to strongly with the psychosocial and sexual well-being scale 6 months after surgery. Subgroup analysis based on patient characteristics found no differences in outcomes, except for body mass index.
Significant improvement in patient-reported satisfaction with breasts, psychosocial well-being, and sexual well-being can be seen 6 months after breast augmentation, despite a decline in physical well-being after treatment. Postoperative satisfaction levels did not depend on preoperative scores. These insights can contribute to improving preoperative communication between surgeon and patient regarding the expected outcomes.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
评估乳房隆乳术的成功,从患者的角度衡量结果至关重要,因为一个成功的美学效果,特别是由患者决定的。本研究旨在使用经过验证的问卷评估接受乳房隆乳术的患者对乳房的满意度以及心理社会、身体和性健康。
这是一项基于正在进行的常规收集数据的多中心队列研究。在术前和术后 6 个月,使用 BREAST-Q 隆乳模块评估患者报告的满意度和健康相关生活质量。
共纳入 1405 例患者。术前和术后 6 个月之间 BREAST-Q 评分(范围 0 至 100)发生了较大变化,乳房满意度(平均,效应大小:+57,3.8)、心理社会健康(平均,效应大小:+38,2.1)、身体健康(平均,效应大小:-14,-1.2)和性健康(平均,效应大小:+44,2.4)。此外,所有四个量表的改善均不依赖于其术前得分,并且所有术后得分都达到了相似的水平。术后测量到胸部的身体健康状况下降。乳房满意度量表与术后 6 个月的心理社会和性健康量表呈中度至强相关。基于患者特征的亚组分析发现,除了体重指数外,结果没有差异。
尽管治疗后身体健康状况下降,但在乳房隆乳术后 6 个月仍能明显提高患者对乳房、心理社会健康和性健康的满意度。术后满意度水平不依赖于术前评分。这些发现有助于改善术前医生与患者之间关于预期结果的沟通。
临床问题/证据水平:治疗性,IV。